These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
805 related articles for article (PubMed ID: 12489115)
1. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice. Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115 [TBL] [Abstract][Full Text] [Related]
2. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice. Zimmer DM; Harbach PR; Mattes WB; Aaron CS Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous and ethylnitrosourea-induced mutation fixation and molecular spectra at the lacI transgene in the Big Blue rat-2 embryo cell line. Zimmer DM; Zhang XB; Harbach PR; Mayo JK; Aaron CS Environ Mol Mutagen; 1996; 28(4):325-33. PubMed ID: 8991060 [TBL] [Abstract][Full Text] [Related]
4. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980 [TBL] [Abstract][Full Text] [Related]
5. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice. Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066 [TBL] [Abstract][Full Text] [Related]
6. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Recio L; Saranko CJ; Steen AM Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839 [TBL] [Abstract][Full Text] [Related]
7. Effects of O (6)-alkylguanine-DNA alkyltransferase deficiency in Escherichia coli as the host for the detection of mutations in lacI transgenic mice. Sui H; Suzuki M; Yamada M; Hara T; Kawakami K; Shibuya T; Nohmi T; Sofuni T Environ Mol Mutagen; 1999; 34(2-3):221-6. PubMed ID: 10529748 [TBL] [Abstract][Full Text] [Related]
8. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice. Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067 [TBL] [Abstract][Full Text] [Related]
9. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice. Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740 [TBL] [Abstract][Full Text] [Related]
10. A novel germline mutation in Big Blue mice. Crabbe RA; Prtenjaca A; Tarnowski HE; Hill KA Environ Mol Mutagen; 2009 Mar; 50(2):114-20. PubMed ID: 19107908 [TBL] [Abstract][Full Text] [Related]
12. Frequency and spectrum of ENU-induced mutation in the Phi X174 transgene in mouse splenic lymphocytes and their significance to spontaneous transgenic rodent mutation frequencies. Valentine CR; Rainey HF; Farrell JM; Shaddock JG; Dobrovolsky VN; Delongchamp RR Mutagenesis; 2008 Sep; 23(5):383-97. PubMed ID: 18504270 [TBL] [Abstract][Full Text] [Related]
13. In vivo mutation analysis using the ΦX174 transgenic mouse and comparisons with other transgenes and endogenous genes. Valentine CR; Delongchamp RR; Pearce MG; Rainey HF; Dobrovolsky VN; Malling HV; Heflich RH Mutat Res; 2010 Dec; 705(3):205-16. PubMed ID: 20637298 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous mutants recovered from liver and germ cell tissue of low copy number lacI transgenic rats. de Boer JG; Erfle H; Holcroft J; Walsh D; Dycaico M; Provost S; Short J; Glickman BW Mutat Res; 1996 Jun; 352(1-2):73-8. PubMed ID: 8676919 [TBL] [Abstract][Full Text] [Related]
15. Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis. Provost GS; Mirsalis JC; Rogers BJ; Short JM Environ Mol Mutagen; 1996; 28(4):342-7. PubMed ID: 8991062 [TBL] [Abstract][Full Text] [Related]
16. Mutational spectrum of dimethylnitrosamine in the liver of 3- and 6-week-old lacI transgenic mice. de Boer JG; Mirsalis JC; Glickman BW Environ Mol Mutagen; 1999; 34(2-3):80-3. PubMed ID: 10529729 [TBL] [Abstract][Full Text] [Related]
17. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea. Allay E; Veigl M; Gerson SL Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687 [TBL] [Abstract][Full Text] [Related]
18. Transgenic lambda medaka as a new model for germ cell mutagenesis. Winn RN; Majeske AJ; Jagoe CH; Glenn TC; Smith MH; Norris MB Environ Mol Mutagen; 2008 Apr; 49(3):173-84. PubMed ID: 18213652 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts. Watson DE; Cunningham ML; Tindall KR Mutagenesis; 1998 Sep; 13(5):487-97. PubMed ID: 9800194 [TBL] [Abstract][Full Text] [Related]
20. Increased mutant frequency and altered mutation spectrum of the lacI transgene in Wilson disease rats with hepatitis. Sone H; Li YJ; Ishizuka M; Aoki Y; Nagao M Cancer Res; 2000 Sep; 60(18):5080-6. PubMed ID: 11016632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]